Connect with us

New Clinical Cannabis Trials for 2017?

Published

on

Clinical Cannabis TrialsBack in October, The NY Times reported that President Obama had lifted restrictions that allowed researchers to use only low-THC strains of cannabis approved by the Drug Enforcement Administration (DEA) to conduct their research. Just producing this type of strain and obtaining proper approval from authorities took years to acquire, creating distress and anger amongst those waiting for advancements in their treatment.

This is great news for cannabis researchers who’ve been desperately trying to study whether cannabis kills cancerous brain cells or just brain cells in general. Although the strains used must nevertheless be approved by both the DEA and the U.S. Food & Drug Administration (FDA), they will not be limited to just the one type.

That being said, one hopes these new regulations will speed up the results of clinical trials working to obtain more information on the benefits of using cannabis to manage illnesses like epilepsy, cancer and Alzheimer’s.

These types of issues are not specific to American policies. Last month, the Australia Broadcasting Corporation reported on their own inability to move forward with clinical trials involving cannabis and terminally ill cancer patients. The ABC News article states that announcements were made back in December 2014 from New South Wales Premier, Mike Baird about three cannabis trials that would be taking place by early 2016. The clinical trials launched would study cannabis’ impact on pediatric epilepsy, those with terminal cancer and chemotherapy patients. As the end of 2016 approaches, only the pediatric epilepsy trial has begun pushing the other trials back at least another three months.

With these new studies underway, agencies like the DEA and FDA will hopefully get the scientific and medical evidence they’ve been asking for in order to obtain the necessary information regarding the affects of cannabis on brain cells. With any hope, this will lead them to make well-informed decisions concerning the medicinal purposes and therefore the laws surrounding cannabis use.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *